COVID-19–related HCQ shortages affected rheumatology patients worldwideNovember 6, 2020COVID-19 UpdatesRheumatology
Twelve medical groups pen letter opposing UHC copay accumulator programNovember 3, 2020Business of MedicineRheumatologyDermatologyOncologyGastroenterologyPractice Management
Shingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020GastroenterologyVaccinesRheumatologyDermatology
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexateSeptember 16, 2020COVID-19 UpdatesRheumatologyDermatologyGastroenterology
Mega vitamin D harms bone in women, not men, without osteoporosisSeptember 15, 2020EndocrinologyRheumatologyWomen's Health
The evidence is not clear: Rheumatic diseases, drugs, and COVID-19August 17, 2020COVID-19 UpdatesRheumatology
Fracture risk prediction: No benefit to repeat BMD testing in postmenopausal womenAugust 4, 2020RheumatologyWomen's HealthEndocrinology
Doctors hesitated to embrace biosimilar infliximab in first 2 yearsJuly 20, 2020DermatologyGastroenterologyRheumatology
ACR issues guidances for MIS-C and pediatric rheumatic disease during pandemicJune 23, 2020PediatricsCOVID-19 UpdatesMusculoskeletal DisordersRheumatology
EULAR’s COVID-19 recommendations offer no surprisesJune 11, 2020PediatricsCOVID-19 UpdatesRheumatologySurgery
Most rheumatology drugs don’t increase COVID-19 hospitalization riskJune 4, 2020COVID-19 UpdatesRheumatology
